The Therion Biosystems facility occupied a promontory of reclaimed land at the northernmost edge of the Greyharbour industrial zone, where the estuary widened into a grey expanse of mudflats and wheeling gulls. The building had been abandoned for five years, its windows boarded, its car park cracked and colonised by weeds. A chain-link fence surrounded the perimeter, topped with rusting barbed wire that sagged between the posts like tired bunting. The sign at the gate had been removed, but the ghost of the letters remained, faded into the paint: a name that no longer meant anything to anyone except, apparently, to whoever had overwritten the molecular tags inside nine dead bodies.
Elara arrived at dawn, alone, in defiance of every regulation the Constabulary had ever written about officer safety and operational procedure. She had not told Carver where she was going. She had not told anyone except Kim, who had insisted on coming and was now standing beside her at the fence, shivering in a waxed jacket that smelled faintly of fish.
“This is where the trail ends,” Kim said. “Therion went bankrupt after its lead product failed clinical trials. A gene therapy for cardiac regeneration. Project Morpheus, they called it. It was supposed to repair damaged heart tissue after a heart attack. It worked beautifully in mice. In humans, it caused the opposite effect. Uncontrolled apoptosis. The heart muscle simply died. Three patients in the Phase 1 trial suffered fatal cardiac events within forty-eight hours of administration. The company buried the data and collapsed before the regulators could investigate. The CEO moved to South America. The research team scattered. The intellectual property was sold at auction to a shell company that no one ever traced.”
“Until now,” Elara said.
“Until now, someone has been using Therion’s technology inside NovaCure’s clinical trial. Replicating the same mechanism. The same liposomal delivery. The same caspase payload. But refined. Improved. The deaths in the original trial took two days. These deaths take weeks. The dose is being calibrated. Whoever is doing this is not just killing people. They are learning how to kill them better.”
Elara tested the fence. A section near the gate had been cut, the chain links peeled back with bolt cutters. The cut was recent. The exposed metal had not yet rusted. Someone else had been here, and recently enough that the salt air had not had time to do its work.
They slipped through the gap and crossed the car park. The main entrance was sealed with a steel shutter, but a side door had been forced. The lock hung from its housing, the screws still bright. Inside, the building was a cathedral of neglect. Dust covered every surface, thick as felt. The air was cold and still, carrying the mineral scent of damp concrete. Laboratory benches stretched away into the gloom, their surfaces bare. The valuable equipment had been auctioned off years ago. What remained was the detritus of a failed enterprise: filing cabinets with their drawers pulled open, cardboard boxes sagging with moisture, a single office chair lying on its side as if the last occupant had fled mid-spin.
Kim moved through the space with the ease of someone who had spent her life in laboratories. She ran her fingers along the benches, opened cabinets, peered into the dark corners. “They took everything,” she said. “The centrifuges. The chromatography rigs. The cell culture incubators. Anything that could be sold.”
“But not the files,” Elara said, pointing to a door at the far end of the room. It was heavier than the others, steel-framed, with a keypad lock that had long since lost power. The door stood slightly ajar.
The room beyond was small, windowless, lined with metal shelving. The shelves held binders, hundreds of them, arranged in chronological order. Research notebooks. Trial protocols. Patient records. All the documentation that a pharmaceutical company was required by law to preserve for fifteen years after a trial ended. Therion had not preserved it. Therion had abandoned it, along with everything else, trusting that no one would ever come looking.
Kim pulled a binder from the shelf and opened it. The pages were dense with data. Laboratory results. Chemical structures. Handwritten annotations in the margins. “This is the original formulation,” she said. “The one that failed. The one that killed three people.” She turned the pages. “But these annotations—they are not from the trial. They are newer. Look at the dates.”
Elara looked. The annotations were written in a different hand, a different ink. They dated from two years ago, three years ago, four years ago. Someone had been here, long after the company collapsed, studying the records. Refining the formula. Someone with access to the building, or at least the lock-picking skills to gain entry. Someone who knew exactly what they were looking for.
“This is a research programme,” Kim said. “A clandestine one. Someone took Therion’s failure and turned it into a weapon. But why? Why go to all this trouble? There are easier ways to kill people. Cheaper ways. Why spend years perfecting a murder weapon that looks like a heart attack?”
Elara was not listening. She had found something else, tucked behind the binders on the bottom shelf. A laptop. An old model, thick and heavy, its casing scuffed. It had been hidden deliberately, wedged between two files in a way that suggested concealment rather than storage. She pulled it out and opened it. The screen was cracked, but when she pressed the power button, it flickered to life.
The battery was low. Seven percent. The operating system loaded, and the desktop appeared. It was cluttered with folders, each one labelled with a date and a code she did not recognise. She opened the most recent folder and found a document. A diary. The text was dense, written in the kind of technical language that made her head ache, but certain phrases leapt out. Cohort four. Dosage escalation. Terminal event. And at the bottom of the page, a single line in bold: The subjects are not patients. They are replicates. The trial is not a trial. It is a demonstration.
“Kim,” she said. “Read this.”
Kim took the laptop and read in silence. Her face, already pale in the cold light, grew paler. “This was written by a whistle-blower. Someone inside NovaCure. Or someone who used to be inside. They are describing the St. Aldwyn’s trial, but they are not describing a clinical study. They are describing a performance. A proof of concept. The drug is not being tested for safety. The drug is being tested for lethality. The goal is to determine the precise dose at which the heart stops, and the precise timeline over which the liposome degrades, and the precise conditions under which a coroner will write ‘natural causes’ without a second thought.”
“A demonstration,” Elara said. “For whom?”
“I don’t know. The document does not say. It just says the trial is a demonstration. A demonstration of capability. A demonstration that the technology works. That it can kill undetectably. That it can be deployed at scale. And the subjects, the residents of St. Aldwyn’s—they are just the proof. The evidence that the weapon is real.”
The screen flickered. Five percent. Elara pulled out her phone and began photographing the screen, page by page, as fast as she could. The text was dense, the light was poor, and her hands were shaking. She did not know if she was capturing enough. She did not know if any of it would be legible. But she kept photographing, page after page, while Kim held the laptop steady and the battery indicator ticked downward.
Three percent. She reached the end of the diary and found a separate file, encrypted, that she could not open. She photographed the icon anyway, the filename a string of alphanumeric characters that might mean something to someone with the right tools. Then the screen went black.
“We need to take this,” Elara said. “The whole laptop.”
“We cannot. It is evidence. If we remove it from the scene, any defence lawyer will argue chain of custody. It will be inadmissible.”
“If we leave it here, someone else will take it. Someone has been here before us. The cut fence. The forced door. They were looking for something. They may not have found it. But they will be back.”
Kim looked at the dead laptop. “Then we copy the hard drive. I have the equipment at the boathouse. But we need to move now. If someone else is watching this place—”
A sound cut through the silence. A door closing, somewhere in the building. The sound was distant, muffled by walls and dust, but unmistakable. Footsteps. Slow, deliberate, moving through the main laboratory. Elara pressed herself against the wall. Kim froze, the laptop clutched to her chest like a shield.
The footsteps paused. A man’s voice, low and calm, spoke a single word she could not quite catch. A second voice answered. Two men, then. Maybe more. They were moving through the space, checking the benches, opening doors. They were searching for something. The same thing she had found.
Elara looked around the small archive room. There was no second exit. No window. No duct large enough to crawl through. The only way out was the door they had entered, and the men were on the other side of it, moving closer.
She pulled Kim down behind the shelving unit, into the corner where the shadows were deepest. The laptop went under a pile of loose papers. Elara drew her service weapon, a gesture that felt absurd in this dust-choked room full of dead files and dead companies and dead patients. She had never fired it outside the range. She was not sure she could fire it now. But the weight of it in her hand was something. An anchor. A reminder that she was still a police officer, even if she was a long way from anywhere the law would recognise as her jurisdiction.
The footsteps reached the archive room door. A hand pushed it open. The hinges creaked. A beam of torchlight swept across the shelves, passing inches from where Elara crouched. She held her breath. Kim closed her eyes. The beam paused. The silence stretched.
Then the torch clicked off. The footsteps retreated. The door swung shut. The voices faded, moving toward the far end of the building, and then there was only the sound of the wind through the broken windows and the distant cry of gulls.
Elara waited ten full minutes before she moved. Her knees ached. Her hand, still wrapped around the pistol, was cramped and cold. She holstered the weapon and helped Kim to her feet. The laptop went into Kim’s bag. They slipped out of the archive room, through the main laboratory, and out the side door into the grey dawn light. The car park was empty. No vehicle. No sign of the men except a single fresh footprint in the mud by the gate.
They drove back through the industrial zone in silence. The streets were empty, the retail parks still shuttered. The world had not yet woken up. Elara felt as if she had crossed into a different time zone, a place where the clocks ran at a different speed. The normal world—the world of morning commutes and office coffee and Superintendent Carver’s weary dismissal—seemed impossibly distant. She was carrying a stolen laptop containing a dead man’s diary, fleeing from unidentified pursuers who had almost certainly been sent by a pharmaceutical company to destroy evidence of a crime that the law had no language for. The absurdity of it was almost comforting. If the situation was ridiculous, it could not also be terrifying. But it was. It was both.
At the boathouse, Kim connected the laptop to a power supply and began the process of copying the hard drive. Elara stood at the window, watching the tide come in, and thought about the diary entry. The subjects are not patients. They are replicates. The trial is not a trial. It is a demonstration. A demonstration for whom? Who would pay to see old people die? Who would commission a proof of concept for a murder weapon that looked like a heart attack?
The answer, when it came, was obvious. It had been obvious all along, but she had been too focused on the mechanism to see the market. A murder weapon that looked like a heart attack was not a product for a single killer. It was a product for an industry. An industry that dealt in deniability. An industry that needed people to die quietly, naturally, without scandal or investigation. Governments. Intelligence services. Private military contractors. The kind of organisations that had budgets for research and development and no interest in leaving fingerprints.
But that was speculation. She had no evidence. She had a diary written by a whistle-blower who might already be dead, and a laptop that would never be admissible in court, and a toxicologist whose career had been destroyed by the very industry they were investigating. She had a photograph of seven dead people and a date that meant something she could not yet decipher. She had fragments. Pieces. The outline of a shape that she could feel but not yet see.
Kim looked up from her work. “The hard drive is intact. The encrypted file is still encrypted. I cannot break it. But I know someone who might. A friend at the university. A cryptographer. She owes me a favour. But it will take time.”
“How much time?”
“A day. Maybe two. And I will need to take the laptop to her. She will not work remotely. She is careful. After what happened to me, everyone is careful.”
“Do it,” Elara said. “Whatever it takes.”
Kim nodded and turned back to the screen. Outside, the tide was fully in, the water lapping at the pilings beneath the boathouse. The world was full of sounds that had been there all along, sounds Elara had stopped hearing years ago. The cry of gulls. The creak of timber. The slow, patient rhythm of the sea. She listened to them now, and felt, for the first time in days, something like clarity. The case was not a case. It was a war. A war between two ways of seeing the world. One that looked at an old woman dead of a heart attack and saw nature taking its course. And one that looked at the same woman and saw a demonstration. A proof of concept. A message sent in a language that no one had yet learned to read.
Her phone buzzed. A text message from an unknown number. She opened it and read, in full: Stop looking. For your own safety. This is not a request.
She showed the phone to Kim. Kim read the message and said nothing. But her hands, resting on the keyboard, were trembling. The threat was not specific. It did not need to be. They both knew what it meant. The men in the building had seen something, or sensed something, or simply been ordered to warn anyone who came too close. The warning had been delivered. The next step would not be a text message.
Elara typed a reply anyway, knowing it was futile, knowing it was probably the last thing she should do. Then I am on the right track. She pressed send and turned off the phone. She was tired. She was afraid. But she was also, for the first time since she had walked into St. Aldwyn’s and seen the photograph on the windowsill, absolutely certain. The machine was real. The machine was running. And she had just found its blueprint.
No comments yet. Be the first to comment!